FindTrial
Sign In

Analyzing association between gout and incidence of neurodegenerative disease (motor neuron disease, dementia) with data from Health Insurance Review and Assessment Servuce

Association between gout and incidence of neurodegenerative diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0006241
Enrollment
195200
Registered
2021-06-10
Start date
2020-02-04
Completion date
Unknown
Last updated
2021-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Hanyang University Guri Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All patients who visited medical institution with the ICD codes M100 and M109 from 2011 to 2013, took gout treatment-related drugs, and visited medical institutions twice or more with the above diagnosis code for 4 weeks or more.

Exclusion criteria

Exclusion criteria: Patients who registered diagnosis code of F01~F03, G30, G31.00~04, G31.82, G12.20-G12.28 from 2007 to 2010.

Design outcomes

Primary

MeasureTime frame
The incidence of amyotrophic lateral sclerosis (ALS), frontotemporal dementia, and lewy body dementia.—

Secondary

MeasureTime frame
The incidence of motor neuron diseases and total dementia—

Countries

Korea, Republic of

Contacts

Public ContactHyuk Sung Kwon

Hanyang University Guri Hospital

hamohamo1318@gmail.com+82-31-560-2260

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026